• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优先结局间相关性对广义成对比较净获益及其估计值的影响。

Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons.

机构信息

Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Graduate School of Interdisciplinary Information Studies, The University of Tokyo, Tokyo, Japan.

出版信息

Stat Med. 2023 May 10;42(10):1606-1624. doi: 10.1002/sim.9690. Epub 2023 Feb 27.

DOI:10.1002/sim.9690
PMID:36849124
Abstract

Benefit-risk balance is gaining interest in clinical trials. For the comprehensive assessment of benefits and risks, generalized pairwise comparisons are increasingly used to estimate the net benefit based on multiple prioritized outcomes. Although previous research has demonstrated that the correlations between the outcomes impact the net benefit and its estimate, the direction and magnitude of this impact remain unclear. In this study, we investigated the impact of correlations between two binary or Gaussian variables on the true net benefit values via theoretical and numerical analyses. We also explored the impact of correlations between survival and categorical variables on the net benefit estimates based on four existing methods (Gehan, Péron, Gehan with correction, and Péron with correction) in the presence of right censoring via simulation and application to actual oncology clinical trial data. Our theoretical and numerical analyses revealed that the true net benefit values were impacted by the correlations in various directions depending on the outcome distributions. With binary endpoints, this direction was governed by a simple rule with a threshold of 50% for a favorable outcome. Our simulation showed that the net benefit estimates based on Gehan's or Péron's scoring rule could be substantially biased in the presence of right censoring, and that the direction and magnitude of this bias were associated with the outcome correlations. The recently proposed correction method greatly reduced this bias, even in the presence of strong outcome correlations. The impact of correlations should be carefully considered when interpreting the net benefit and its estimate.

摘要

获益-风险平衡在临床试验中受到越来越多的关注。为了全面评估获益和风险,广义的成对比较越来越多地被用于基于多个优先结局来估计净获益。尽管先前的研究已经表明结局之间的相关性会影响净获益及其估计值,但这种影响的方向和程度尚不清楚。在这项研究中,我们通过理论和数值分析研究了两个二项或高斯变量之间的相关性对真实净获益值的影响。我们还通过模拟和实际肿瘤学临床试验数据的应用,探讨了在存在右删失的情况下,生存和分类变量之间的相关性对基于四种现有方法(Gehan、Péron、Gehan 校正和 Péron 校正)的净获益估计值的影响。我们的理论和数值分析表明,真实的净获益值受到结局分布的不同方向的相关性的影响。对于二分类结局,这种方向由一个简单的规则控制,对于有利结局的阈值为 50%。我们的模拟表明,在存在右删失的情况下,基于 Gehan 或 Péron 评分规则的净获益估计值可能会出现显著的偏倚,并且这种偏倚的方向和程度与结局相关性有关。最近提出的校正方法即使在存在强烈的结局相关性的情况下,也能大大减少这种偏倚。在解释净获益及其估计值时,应该仔细考虑相关性的影响。

相似文献

1
Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons.优先结局间相关性对广义成对比较净获益及其估计值的影响。
Stat Med. 2023 May 10;42(10):1606-1624. doi: 10.1002/sim.9690. Epub 2023 Feb 27.
2
An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring.存在删失时优先结局的广义成对比较的扩展。
Stat Methods Med Res. 2018 Apr;27(4):1230-1239. doi: 10.1177/0962280216658320. Epub 2016 Aug 2.
3
The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.肿瘤临床试验中因治疗转换而导致的时间事件结局的净获益。
Clin Trials. 2023 Dec;20(6):670-680. doi: 10.1177/17407745231186081. Epub 2023 Jul 16.
4
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study.使用广义成对比较法在存在相关优先结果的情况下的净效益:一项模拟研究。
Stat Med. 2021 Feb 10;40(3):553-565. doi: 10.1002/sim.8788. Epub 2020 Nov 2.
5
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.基于广义成对比较的涉及竞争风险的临床试验中治疗效果的新度量。
Biom J. 2021 Feb;63(2):272-288. doi: 10.1002/bimj.201900354. Epub 2020 Sep 16.
6
Correcting the bias of the net benefit estimator due to right-censored observations.校正由于右删失观测导致的净收益估计量的偏差。
Biom J. 2021 Apr;63(4):893-906. doi: 10.1002/bimj.202000001. Epub 2021 Feb 22.
7
Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancer.随访对估计晚期/转移性胃癌伊立替康获益的广义成对比较的影响。
Contemp Clin Trials. 2021 Jun;105:106400. doi: 10.1016/j.cct.2021.106400. Epub 2021 Apr 15.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
The asymptotic distribution of the Net Benefit estimator in presence of right-censoring.存在右删失时净效益估计量的渐近分布。
Stat Methods Med Res. 2021 Nov;30(11):2399-2412. doi: 10.1177/09622802211037067. Epub 2021 Oct 11.
10
Restricted Net Treatment Benefit in oncology.肿瘤学中的受限网络治疗获益。
J Clin Epidemiol. 2024 Jun;170:111340. doi: 10.1016/j.jclinepi.2024.111340. Epub 2024 Apr 1.

引用本文的文献

1
The Evolving Role of PSMA-PET/CT in Prostate Cancer Management: an Umbrella Review of Diagnostic Restaging, Therapeutic Redirection, and Survival Impact.PSMA-PET/CT在前列腺癌管理中不断演变的作用:关于诊断性再分期、治疗调整及生存影响的综合综述
Curr Oncol Rep. 2025 May 14. doi: 10.1007/s11912-025-01682-2.